Hansa Biopharma AB (HNSBF)
2.83
0.00 (0.00%)
USD |
OTCM |
Dec 16, 16:00
Hansa Biopharma Total Assets (Quarterly): 93.30M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abliva AB | 9.605M |
| Oncopeptides AB | 27.02M |
| BioInvent International AB | 107.86M |
| BioArctic AB | 108.41M |
| Camurus AB | 353.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 125.03M |
| Shareholders Equity (Quarterly) | -31.73M |
| Debt to Equity Ratio | -2.947 |
| Current Ratio | 2.451 |
| Net Debt Paydown Yield | -1.67% |